BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10638559)

  • 1. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L; Howden CW
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ranitidine on intragastric pH in clinically normal neonatal foals.
    Sanchez LC; Lester GD; Merritt AM
    J Am Vet Med Assoc; 1998 May; 212(9):1407-12. PubMed ID: 9589127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
    Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules.
    Ono S; Kato M; Ono Y; Imai A; Yoshida T; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2009 Apr; 24(4):639-45. PubMed ID: 19032447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of acid suppression during dosing with H2-receptor antagonists.
    Wilder-Smith C; Halter F; Ernst T; Gennoni M; Zeyen B; Varga L; Roehmel JJ; Merki HS
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():15-27. PubMed ID: 1983344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist.
    Takahashi M; Katayama Y
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1493-7. PubMed ID: 20796145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.
    Ley LM; Becker A; Lühmann R; Sander P; Lücker PW
    Methods Find Exp Clin Pharmacol; 2005; 27(1):25-9. PubMed ID: 15834456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens.
    Adachi K; Komazawa Y; Fujishiro H; Mihara T; Ono M; Yuki M; Kawamura A; Karim Rumi MA; Amano Y; Kinoshita Y
    J Gastroenterol; 2003; 38(9):830-5. PubMed ID: 14564627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA; Lanzon-Miller S; Pounder RE
    Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
    Mathôt RA; Geus WP
    Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding.
    Fiorucci S; Clausi GC; Farinelli M; Santucci L; Pelli MA; Morelli A
    Am J Gastroenterol; 1989 Nov; 84(11):1416-20. PubMed ID: 2816875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
    Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour intragastric pH-metry: H2-receptor antagonist restoration of nightly gastric spontaneous alkalinization in duodenal ulcer healing.
    Bianco A; Cagossi M; Piraccini R; Greco AV
    Riv Eur Sci Med Farmacol; 1992; 14(5):281-91. PubMed ID: 1364062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.
    Walt RP; Malé PJ; Hunt RH; Rawlings J; Milton-Thompson GJ; Misiewicz JJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():33-7. PubMed ID: 6119780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked rebound acid hypersecretion after treatment with ranitidine.
    el-Omar E; Banerjee S; Wirz A; Penman I; Ardill JE; McColl KE
    Am J Gastroenterol; 1996 Feb; 91(2):355-9. PubMed ID: 8607506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.